Dorman Products Inc. reported adjusted diluted EPS of $3.08 for the second quarter, a 50% increase that exceeds the consensus estimate of $1.95. This significant profit surge is bolstered by strong cash flow and a positive outlook for growth in 2026, positioning the company favorably for investors.

Key Highlights

  • Selling, general, and administrative (SG&A) expenses amounted to $135 million, representing 24.8% of sales for the quarter, a marginal reduction from 25.3% the prior year.
  • Dorman's solid earnings appear against a backdrop of mixed market conditions, with sector peers like BWA appreciating by 1.1%, while LEA remained stable.
  • Dorman has adjusted its full-year guidance, expecting net sales growth between 3% and 5%, down from a prior estimate of 7% to 9%.

Dorman Products Inc. (NASDAQ: DORM) achieved adjusted diluted earnings per share of $3.08 in the second quarter, marking a 50% improvement year-over-year that surpassed analyst expectations, which pegged EPS at $1.95. This performance aligns with the company’s release detailing net sales of $544.6 million, increasing 0.7% from $541 million a year earlier. With strong earnings bolstered by an effective tariff recovery strategy, Dorman demonstrates its underlying resilience and potential growth trajectory.

The company's performance is noteworthy, especially considering market volatility this year, thus attracting the interest of investors seeking stability in the consumer sector.

Financial Performance

Selling, general, and administrative (SG&A) expenses amounted to $135 million, representing 24.8% of sales for the quarter, a marginal reduction from 25.3% the prior year. The significant rise in diluted EPS to $2.93, a 53% increase from $1.91 in the previous year, demonstrates efficiency improvements. The special factors influencing this quarter, particularly the IEEPA tariff cost recovery, play a key role in enhancing profitability and cash flow, positioning Dorman to pursue strategic growth investments.

Market Context and Read-Through

Dorman's solid earnings appear against a backdrop of mixed market conditions, with sector peers like BWA appreciating by 1.1%, while LEA remained stable. Dorman’s shares increased 2.9% year-to-date, reflecting investor confidence amidst a challenging month where shares were down 5.9%. Investors might view the current pricing potential within the 52-week range of $98.45 to $166.89 as a testament to ongoing volatility, thus making the company’s recent performance and outlook a notable point of decision-making.

Updated Guidance for 2026

Dorman has adjusted its full-year guidance, expecting net sales growth between 3% and 5%, down from a prior estimate of 7% to 9%. The revised diluted EPS forecast ranges from $7.93 to $8.23, reflecting continued optimism contrasted with prior expectations of slower growth. The company attributes this shift to evolving market conditions while emphasizing its strengthened balance sheet and increased liquidity through debt refinancing.

Investors should monitor the upcoming conference call on August 4 for additional insights into how Dorman plans to navigate these adjustments while continuing to deliver value to shareholders.

Peers Moving on This News

  • Borgwarner Inc (BWA) up 1.1%
  • Lear Corp (LEA) little changed

Analysis based on the Form 8-K filed 3 August 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.